A new research paper documents the outcomes of five volunteers who continued to receive 40Hz light and sound stimulation for ...

The Quest AD-Detect® blood-based test panels deliver confirmatory accuracy, potentially supporting reduced reliance on ...

An AI system has been designed to aid cancer diagnosis, providing insights into subtyping, biomarker quantification, ...

A new research paper documents the outcomes of five volunteers who continued to receive 40Hz light and sound stimulation for ...

Investors expecting an upbeat update at CSL's AGM have been left disappointed, with low US vaccination rates prompting an ...

A long-term study found that daily 40Hz light and sound stimulation may help slow cognitive decline in people with late-onset Alzheimer’s disease.

Amgen Inc (($AMGN)) announced an update on their ongoing clinical study. Amgen Inc. is currently conducting a clinical study titled An Open-Label ...

Clinical and Pharmacology Data Presented at ACR Convergence 2025In a Phase II trial, LEVI-04 demonstrated a significant, dose-dependent reduction in bone marrow lesions (BML) compared with placebo in ...

Health Canada grants authorization for Leqembi to treat early Alzheimer’s disease: Stockholm Tuesday, October 28, 2025, 10:00 Hrs [IST] BioArctic AB’s (publ) partner Eisai ann ...

Two new studies suggest that maintaining good oral health could be more than just good hygiene — it might lower the risk for ...

Considering the range of experiences academics encounter in university environments, from collegiality to subtle hostility, ...